Upper GI Cancer Research Review Issue 1

In this issue:

Current and future global patterns of gastric cancer
First-line treatment with chemotherapy + sintilimab for oesophageal SCC
First-line treatment with chemotherapy + immunotherapy for advanced biliary tract cancer
Perioperative nivolumab ± ipilimumab for resectable hepatocellular carcinoma
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma
Chemoradiotherapy + immunotherapy for locally advanced oesophageal SCC
Gemcitabine ± nab-paclitaxel after FOLFIRINOX failure in metastatic pancreatic adenocarcinoma
Pembrolizumab for advanced hepatocellular carcinoma in patients previously treated with sorafenib
ctDNA correlates with tumour burden and predicts outcome in pancreatic cancer
A diagnostic model to identify prevalent malignant oesophageal lesions

Please login below to download this issue (PDF)

Subscribe